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We would like to thank Cheung et al. for their comments on possible genetic 
associations between neonatal sclerosing cholangitis (NSC) and primary sclerosing 
cholangitis (PSC). Cheung et al., through whole exome sequencing in a group of 67 
(30 under 18 years old) patients diagnosed with PSC identified three missense 
variants in doublecortin domain containing 2 (DCDC2) gene [c.1368A>T; 
p.(Lys456Asn), c.661A>G; p.(Ser221Gly) and c.454C>G; p.(Pro152Ala)] with 
minimal predicted effect on protein function. These are all common variants, with 
c.661G in fact being more common than c.661A in all populations examined. PSC 
does not behave as Mendelian trait. There is however an increased occurrence of 
other autoimmune diseases in families [1]. Relatively common variants in cilial genes 
might still predispose bile ducts to being the target of autoimmunity in a particular 
individual. It would be important to examine the frequency of these variants 
compared to matched controls, or possibly use other forms of association studies such 
as the Transmission Disequilibrium Test, if trios were available,  
In our cohort of NSC patients [2] we identified the same 3 missense variants in 
patients with or without disease-causing mutations in DCDC2. Immunohistochemical 
studies in NSC patients with only the above-mentioned missense variants showed 
preservation of DCDC2 protein and acetylated alpha-tubulin. 
Although no disease causing variants in cilia related genes have been so far identified 
in patients with PSC the altered expression and mislocalisation of cilial proteins could 
still be implicated in the disease pathogenesis of PSC [3-5]. It has been suggested 
though that this effect is more likely part of a secondary sequalae of changes in the 
biliary microenvironment rather than the primary cause [6]. 
The pathophysiological mechanisms, by which common genetic variants with 
minimal isolated functional effect, can play a contributory role in the ciliopathy 
phenotype should remain under investigation. Such a mechanism is the one suggested 
in animal models of Meckel, Nephronophthisis and Bardet-Biedl syndromes [7] 
where all 3 complexes contribute synergistically to variability in ciliogenesis. The 
complexity of the interactions amongst different ciliary structures and their function 
remains a challenging field for researchers. 
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